Empagliflozin/Metformin Tablets 5/500 mg
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharm Co., Ltd.
MFDS item code 202201401 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to help control blood sugar levels in adult patients with type 2 diabetes by using empagliflozin and metformin together. Administration with dietary modifications and exercise can enhance blood sugar control. Special caution is needed for patients with type 2 diabetes where blood sugar is poorly controlled and have cardiovascular diseases about the occurrence of cardiovascular events. Therefore, proper use under a healthcare professional's guidance can effectively manage blood sugar.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps in controlling blood sugar levels, acting through its two active ingredients used for diabetes treatment. It can cause a rare but very serious condition called lactic acidosis, so it should not be used by patients with impaired kidney function, severe infections, dehydration, or heart problems. Additionally, when used with insulin or other antihyperglycemic agents, there is a risk of hypoglycemia, so caution is advised. Patients with reduced kidney function, elderly patients, or those in a dehydrated state should consult with a physician before using this medication and undergo regular kidney function tests. During treatment, gastrointestinal disturbances such as nausea, vomiting, and diarrhea may occur, and there is also a risk of urinary or genital infections, so any symptoms that arise should be reported immediately to healthcare professionals. It is advisable for pregnant women or those who may become pregnant and nursing mothers to avoid using this medication. Patients scheduled for surgery should stop taking this medication 48 hours before the procedure and can resume it after confirming normal kidney function post-surgery. This medication can lead to fluid loss; hence, patients with low blood pressure or dehydration symptoms should use it cautiously, and those aged 75 and older should be particularly careful. Excessive alcohol consumption should be avoided during treatment as it may increase the risk of lactic acidosis. Regular monitoring of blood sugar and kidney function is recommended while on this medication, as well as monitoring vitamin B12 levels. If severe abdominal pain, difficulty breathing, severe fatigue, or altered consciousness occurs after taking this medication, the patient must immediately visit a healthcare facility. This medication can interact with other drugs, so patients should inform their doctor or pharmacist of any other medications they are taking. Lastly, this medication is not recommended for children or adolescents under 18 years of age, and it should always be taken as directed by a physician.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture ingress, and the temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's effectiveness and prevent deterioration.
Orange-yellow, biconvex, oval film-coated tablets
10 tablets/box [10 tablets/PTP*1], 60 tablets/box [10 tablets/PTP*6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharm Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.